What Are the Side Effects of GLP-1 Drugs?

Updated July 2026

GLP-1 medications are effective, and for a growing list of conditions they genuinely help. But the downsides are real, and they aren't rare. Anyone considering these drugs — or already taking them — deserves a clear, honest picture of what can go wrong, and an equally honest account of when they're truly worth it.

What are the common side effects?

Mostly digestive, and mostly a matter of degree. The same slowed digestion that makes you feel full longer can, pushed too far, cause nausea, vomiting, constipation, and diarrhea. About 80% of people taking these medications experience at least one of these, more so at higher doses. For most, the symptoms are mild to moderate, tend to ease over time, and improve with slow, careful dose increases — but they're also the single most common reason people stop. Rarely, digestion can slow to a near halt and cause a bowel obstruction, which is a medical emergency.

Do GLP-1 drugs make surgery riskier?

Yes, and it's important to plan for. Because these drugs slow how quickly the stomach empties, food can linger there longer than expected, which raises the risk of complications under anesthesia — particularly aspiration, where stomach contents get into the lungs. If you have elective surgery scheduled, you'll very likely be told to hold at least one dose beforehand. In an emergency, when there's no time to prepare, simply being on a GLP-1 drug raises your surgical risk.

Can they cause dehydration or kidney problems?

They can. The same signal that dampens appetite also dampens thirst, so people on GLP-1 drugs can drink too little without noticing. Prolonged or severe dehydration can, in turn, injure the kidneys. The fix is simple but requires attention: drink enough that your urine stays relatively clear.

What about the risk of gallstones and pancreatitis?

Both are elevated. Rapid weight loss raises the risk of gallstones and gallbladder disease that can require surgery. And while it's relatively uncommon, some people develop pancreatitis — inflammation of the pancreas. The pancreas makes digestive enzymes and normally routes them out through small channels; when it becomes inflamed, those channels can swell shut and the organ effectively begins to digest itself. It's intensely painful, can be life-threatening, and the scarring it leaves behind narrows those channels permanently, setting up a cycle of future attacks. Pancreatitis is rare, but along with bowel obstruction it's the side effect clinicians worry about most.

Do GLP-1 drugs cause thyroid cancer?

Probably not, though the question has a history. Early rodent studies showed a rare type of thyroid tumor, which is why these drugs carry an FDA boxed warning. But the human evidence has since grown substantially, and large studies following tens of thousands of people have found no meaningful increase in thyroid cancer. The one clear exception: anyone with a personal or family history of medullary thyroid cancer or the genetic syndrome MEN2 should not take these drugs, and that caution still stands.

Do the benefits outweigh the risks?

For the right person, often yes — but with two caveats that matter enormously. The serious side effects are rare, and obesity itself carries substantial, well-documented harm, so on balance the benefits of meaningful weight loss can outweigh the risks. The catch is what the weight loss is made of, and whether it lasts.

The first caveat is muscle. Weight lost through appetite reduction alone isn't selective — you lose fat and muscle together. Regain the weight later, as most people do, and it comes back mostly as fat, which can leave you metabolically worse off than when you started. Unless you pair these drugs with regular resistance exercise, you're trading muscle you need for a result you won't keep.

The second caveat is the diet underneath. Diet is the primary driver of weight, and unless you change both how much and what you eat, the weight returns when the drug stops. That's why so many people find themselves on these medications indefinitely. GLP-1 drugs are not an easy way out — used well, they come with an exercise program and real dietary change, not instead of them.

When are GLP-1 drugs actually the right call?

In select cases, and they're worth naming clearly. Medications have a role — I founded a food company to help people reduce their need for cholesterol drugs, and I still prescribe statins when they're warranted. The same balance applies here. In my view, these drugs earn their place in a few specific situations: for people with diabetes who can't get blood sugar under control despite genuine dietary effort; for people with heart failure or chronic kidney disease who keep teetering on the edge of hospitalization, where the evidence for benefit is now strongest; and for people who are truly stuck — whose weight so limits their ability to move that no realistic change in diet alone can shift the balance, making a GLP-1 drug a reasonable alternative to gastric bypass surgery.

Losing weight and keeping it off is genuinely hard, and none of this is a judgment of anyone who struggles with it. It's simply the honest clinical picture: powerful drugs, real risks, and a narrower set of ideal candidates than the advertising would suggest.

The bottom line

GLP-1 medications can be the right tool for the right person, but they are neither a shortcut nor a cure. They carry real risks, they cost you muscle if you're not careful, and they stop working when you stop taking them — unless the underlying diet changes. Which raises the obvious question, and the subject of the last piece in this series: if the real driver is food, can you raise GLP-1 naturally, with what you eat?

If you're new to this site and found this useful, I write one of these evidence-based articles every week. You can get them in your inbox by joining my email list at the bottom of this page. No spam, no requirement to buy anything, just practical knowledge.